Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 3 (2006), Issue 7 (July)

1. Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults.
   Leuk Res, 30(9): 1091-6. [Abstract] [Full-text]
2. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
   Leuk Res, 30(9): 1159-65. [Abstract] [Full-text]
3. Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes.
   Leuk Res, 30(9): 1097-104. [Abstract] [Full-text]
4. Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia.
   Leuk Res, 30(9): 1105-12. [Abstract] [Full-text]
5. Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia.
   Leukemia, 20(8): 1408-13. [Abstract] [Full-text]
6. Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.
   Leukemia, 20(8): 1361-7. [Abstract] [Full-text]
7. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
   J Clin Oncol, 24(22): 3686-92. [Abstract] [Full-text]
8. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
   J Clin Oncol, 24(22): 3604-10. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.